JAMES HEALY Insider Trading $ITRM Iterum Therapeutics plc
Get free email notifications about insider trading for JAMES HEALY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES HEALY. JAMES HEALY is Director in AMARIN CORP PLC\UK ($AMRN) and Director in INTERMUNE INC ($ITMN) and Director in HYPERION THERAPEUTICS INC ($HPTX) and Director in Edge Therapeutics, Inc. ($EDGE) and Director in Coherus BioSciences, Inc. ($CHRS) and Director in Bolt Biotherapeutics, Inc. ($BOLT) and in Natera, Inc. ($NTRA) and Director in Natera, Inc. ($NTRA) and Director in Iterum Therapeutics plc ($ITRM) and Director in Y-mAbs Therapeutics, Inc. ($YMAB) and in Karuna Therapeutics, Inc. ($KRTX) and Director in Karuna Therapeutics, Inc. ($KRTX).
JAMES HEALY in Iterum Therapeutics plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JAMES HEALY: Director
Holdings: 6,154 shares
Latest Transaction: Jun 17 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JAMES HEALY in Iterum Therapeutics plc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMRN, BOLT, CHRS, HPTX, ITMN, ITRM, KRTX, NTRA, EDGE, YMAB
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2019 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Option Exercise | A | 0.00 | 5,703 | 0 | 5,703 | |
| May 29 2019 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Option Exercise | M | 0.00 | 6,154 | 0 | 0 | |
| May 29 2019 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Buy | M | 0.00 | 6,154 | 0 | 6,154 | 0 to 6.2 K |
| May 30 2018 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 229,660 | 0 | 0 | |
| May 30 2018 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 275,446 | 0 | 0 | |
| May 30 2018 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 721,408 | 0 | 0 | |
| May 30 2018 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Buy | P | 13.00 | 500,000 | 6,500,000 | 1,726,514 | 1.2 M to 1.7 M (+40.77 %) |
| May 30 2018 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Buy | C | 0.00 | 229,660 | 0 | 1,226,514 | 996.9 K to 1.2 M (+23.04 %) |
| May 30 2018 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Buy | C | 0.00 | 275,446 | 0 | 996,854 | 721.4 K to 996.9 K (+38.18 %) |
| May 30 2018 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Buy | C | 0.00 | 721,408 | 0 | 721,408 | 0 to 721.4 K |
| May 29 2018 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Option Exercise | A | 0.00 | 6,154 | 0 | 6,154 |
Page: 1